Ikarian Capital, LLC 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:57 pm Purchase | 2022-12-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 138,277 12.500% | 120,820 (+692.10%) | Filing |
| 2023-02-14 11:26 am Sale | 2022-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital, LLC | 11,638 0.300% | -63,845 (-84.58%) | Filing |
| 2022-02-14 4:43 pm Sale | 2021-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital, LLC | 75,483 8.100% | -14,221 (-15.85%) | Filing |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 134,556 13.800% | 89,488 (+198.56%) | Filing |
| 2022-02-14 4:35 pm Purchase | 2021-12-31 | 13G | SCPHARMACEUTICALS INC SCPH | Ikarian Capital, LLC | 901,362 3.300% | 901,362 (New Position) | Filing |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | SCIENCE 37 HLDGS INC SNCE | Ikarian Capital, LLC | 0 0.000% | -131,249 (Position Closed) | Filing |